Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden mice

• Kanita Salic,

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Writing – review & editing

  Affiliation TNO, Department of Metabolic Health Research, Leiden, Netherlands

  ⨯
• Robert Kleemann,

  Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing

  Affiliation TNO, Department of Metabolic Health Research, Leiden, Netherlands

  ⨯
• Cynthia Wilkins-Port,

  Roles Conceptualization, Data curation, Methodology, Writing – review & editing

  Current address: Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America

  Affiliation Shire LLC, now part of Takeda, Cambridge, Massachusetts, United States of America

  ⨯
• John McNulty,

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliation Shire LLC, now part of Takeda, Cambridge, Massachusetts, United States of America

  ⨯
• Lars Verschuren,

  Roles Formal analysis, Writing – review & editing

  Affiliation TNO, Department of Microbiology and Systems Biology, Zeist, Netherlands

  ⨯
• Melissa Palmer

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  * E-mail: melissa.palmer@takeda.com

  Affiliation Shire LLC, now part of Takeda, Cambridge, Massachusetts, United States of America

  http://orcid.org/0000-0002-8745-6865

  ⨯